CryoLife, Inc. (CRY) - Product Pipeline Analysis - New Market Report Now Available

Boston, MA -- (SBWIRE) -- 08/02/2012 -- CryoLife, Inc. (CryoLife) is a biological medical device company that develops and commercializes biomaterials, implantable medical devices and surgical adhesives, and also preserves and distributes human tissues for cardiovascular and vascular transplant applications. The company's product portfolio includes Aortic Valve Allograft, Soft Tissue Repair Matrix, HemoStase, and Pulmonary Artery Trunk Patch, among others. Its products and services are offered in about 75 countries through several distributors. CryoLife operates through two business segments, namely, Preservation Services and Medical Devices segments. The company owns four subsidiaries, namely, CryoLife International, Inc., CryoLife Acquisition Corp., AuraZyme Pharmaceuticals, Inc. and CryoLife Europa, Ltd. It is headquartered in Georgia, the US. Read the full press release at http://www.sbwire.com/press-releases/cryolife-inc-cry-product-pipeline-analysis-new-market-report-now-available-156332.htm